| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Center for Pharmacogenetics (Y.Z., H.V.P., J.Z., W.X.), Department of Pharmaceutical Sciences (Y.Z., H.V.P., J.Z., J.A.A., R.R.V., W.X.), and Department of Medicine (J.A.A.), University of Pittsburgh, Pittsburgh, Pennsylvania 15261
Address all correspondence and requests for reprints to: Dr. Wen Xie, Center for Pharmacogenetics, 633 Salk Hall, University of Pittsburgh, Pittsburgh, Pennsylvania 15261. E-mail: wex6{at}pitt.edu.
The pregnane X receptor (PXR) was isolated as a xenobiotic receptor that regulates responses to various xenobiotic agents. In this study, we show that PXR plays an important endobiotic role in adrenal steroid homeostasis. Activation of PXR by genetic (transgene) or pharmacological (ligand, such as rifampicin) markedly increased plasma concentrations of corticosterone and aldosterone, the respective primary glucocorticoid and mineralocorticoid in rodents. The increased levels of corticosterone and aldosterone were associated with activation of adrenal steroidogenic enzymes, including cytochrome P450 (CYP)11a1, CYP11b1, CYP11b2, and 3ß-hydroxysteroid dehydrogenase. The PXR-activating transgenic mice also exhibited hypertrophy of the adrenal cortex, loss of glucocorticoid circadian rhythm, and lack of glucocorticoid responses to psychogenic stress. Interestingly, the transgenic mice had normal pituitary secretion of ACTH and the corticosterone-suppressing effect of dexamethasone was intact, suggesting a functional hypothalamus-pituitary-adrenal axis despite a severe disruption of adrenal steroid homeostasis. The ACTH-independent hypercortisolism in the PXR-activating transgenic mice is reminiscent of the pseudo-Cushings syndrome in patients. The glucocorticoid effect appears to be PXR specific, as the activation of constitutive androstane receptor in transgenic mice had little effect. We propose that PXR is a potential endocrine disrupting factor that may have broad implications in steroid homeostasis and drug-hormone interactions.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
J. He, Q. Cheng, and W. Xie Minireview: Nuclear Receptor-Controlled Steroid Hormone Synthesis and Metabolism Mol. Endocrinol., January 1, 2010; 24(1): 11 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lichti-Kaiser, D. Brobst, C. Xu, and J. L. Staudinger A Systematic Analysis of Predicted Phosphorylation Sites within the Human Pregnane X Receptor Protein J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 65 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Liu, Y. Takahashi, T. Wada, J. He, J. Gao, Y. Tian, S. Li, and W. Xie The Aldo-Keto Reductase Akr1b7 Gene Is a Common Transcriptional Target of Xenobiotic Receptors Pregnane X Receptor and Constitutive Androstane Receptor Mol. Pharmacol., September 1, 2009; 76(3): 604 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Pondugula, C. Brimer-Cline, J. Wu, E. G. Schuetz, R. K. Tyagi, and T. Chen A Phosphomimetic Mutation at Threonine-57 Abolishes Transactivation Activity and Alters Nuclear Localization Pattern of Human Pregnane X Receptor Drug Metab. Dispos., April 1, 2009; 37(4): 719 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matsumoto, K. Hashimoto, M. Yamada, T. Satoh, J. Hirato, and M. Mori Liver X Receptor-{alpha} Regulates Proopiomelanocortin (POMC) Gene Transcription in the Pituitary Mol. Endocrinol., January 1, 2009; 23(1): 47 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sun, M. Bello-Roufai, and X. Wang RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1880 - H1887. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Healan-Greenberg, J. F. Waring, D. J. Kempf, E. A. G. Blomme, R. G. Tirona, and R. B. Kim A Human Immunodeficiency Virus Protease Inhibitor Is a Novel Functional Inhibitor of Human Pregnane X Receptor Drug Metab. Dispos., March 1, 2008; 36(3): 500 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gong, P. Guo, Y. Zhai, J. Zhou, H. Uppal, M. J. Jarzynka, W.-C. Song, S.-Y. Cheng, and W. Xie Estrogen Deprivation and Inhibition of Breast Cancer Growth in Vivo through Activation of the Orphan Nuclear Receptor Liver X Receptor Mol. Endocrinol., August 1, 2007; 21(8): 1781 - 1790. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Pacyniak, X. Cheng, M. L. Cunningham, K. Crofton, C. D. Klaassen, and G. L. Guo The Flame Retardants, Polybrominated Diphenyl Ethers, Are Pregnane X Receptor Activators Toxicol. Sci., May 1, 2007; 97(1): 94 - 102. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |